Urticaria and angiedema-like skin reactions in a patient treated with adalimumab

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

Michael E. Weinblatt, Edward Keystone, Daniel E. Furst et al. · Arthritis & Rheumatism · 2003 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +15

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden et al. · Arthritis & Rheumatism · 1998 · 1.6K citations

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Etanercept Therapy in Rheumatoid Arthritis

Larry W. Moreland · Annals of Internal Medicine · 1999 · 1.4K citations

Medicine, Pharmacology, Pharmacotherapy +14

Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α

Jennifer D. Gorman, Kenneth E. Sack, John C. Davis · New England Journal of Medicine · 2002 · 707 citations · Full text

Medicine, Immunology, Molecular Biology +13